Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-02-08
2005-02-08
Nguyen, Dave T. (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100, C435S325000, C424S093200
Reexamination Certificate
active
06852703
ABSTRACT:
A vector comprising a nucleotide sequence of interest (“NOI”) encoding a product of interest (“POI”) is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI to the tumor.
REFERENCES:
patent: 4997913 (1991-03-01), Hellstrom et al.
patent: 5559099 (1996-09-01), Wickham et al.
patent: WO 8907947 (1989-09-01), None
patent: WO 9411513 (1994-05-01), None
patent: WO 9615238 (1996-05-01), None
patent: WO 9634969 (1996-11-01), None
patent: 9615238 (1996-05-01), None
Greco O. et al. Cancer gene therapy: ‘delivery, delivery, delivery’. Frontiers in Biosci. 2002; 7:d1516-1524.*
Riddell S.R. et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Medicine 1996; 2:216-221.*
Richter J. et al. Clinical gene therapy in hematology: Past and future. Int. Journ. Hematology. 2001:73:162-169.*
Anderson, Human gene therapy, Apr. 30, 1998. Nature, vol. 392, pp. 25-30*
Walthet et al., Viral Vectors for Gene Transfer, Aug. 2000, Drugs, vol. 2, pp. 249-271.*
Mountain, Gene therapy: the first decade, Mar. 2000, TIBTECH, vol. 18, pp. 119-127.*
Verma et al., Gene therapy-promises. problems and propects. Sept. 18, 1997. Nature, vol. 389, pp. 239-242.*
Ronald S. Chamberlain et al.,Costimulation Enhances the Active Immunotherapy Effect of Recombinant Anticancer Vaccines, Cancer Research, vol. 56, Jun. 15, 1996, pp. 2832-2836.
Bebbington Christopher Robert
Carroll Miles William
Ellard Fiona Margaret
Kingsman Susan Mary
Myers Kevin Alan
Angell Jon Eric
Nguyen Dave T.
Oxford Biomedica (UK) Limited
Townsend and Townsend / and Crew LLP
LandOfFree
Tumor targeted vector does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor targeted vector, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor targeted vector will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3512271